股票 › BIO
伯乐生命医学 BIO
美股市值排名 #1418
$381.57 +$12.57 (+3.41%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $381.57 0.00%
开盘$364.45
昨收$369.00
当日区间$363.59 – $384.62
成交量273.2K
市值$10.26B
市盈率（TTM）10.1
股息率–
财报
财报日平均波动±7.2%近16次财报
收涨次数5 / 1631% 的概率
最佳反应+17.6%
最差反应-16.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±8.4% | +4.50% | 符合区间 |
| 2026/Q1 | 30 Apr 2026 | After Market | ±9.6% | -8.41% | 符合区间 |
| 2025/Q4 | 12 Feb 2026 | After Market | ±10.4% | -12.26% | 超出定价预期 |
| 2025/Q3 | 29 Oct 2025 | After Market | ±8.3% | -4.65% | 符合区间 |
| 2025/Q2 | 31 Jul 2025 | After Market | ±14.9% | +17.63% | 超出定价预期 |
| 2025/Q1 | 1 May 2025 | After Market | ±8.3% | -1.70% | 符合区间 |
| 2024/Q4 | 13 Feb 2025 | After Market | ±8.1% | -9.53% | 超出定价预期 |
| 2024/Q3 | 30 Oct 2024 | After Market | ±11.4% | +8.35% | 符合区间 |
| 2024/Q2 | 1 Aug 2024 | After Market | ±8.2% | -1.56% | 符合区间 |
| 2024/Q1 | 7 May 2024 | After Market | ±8.1% | -4.16% | 符合区间 |
| 2023/Q4 | 15 Feb 2024 | After Market | ±8.9% | +3.59% | 符合区间 |
| 2023/Q3 | 26 Oct 2023 | After Market | ±10.7% | -7.15% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±11.3% | -0.45% | 符合区间 |
| 2023/Q1 | 4 May 2023 | After Market | ±8.0% | -16.72% | 超出定价预期 |
| 2022/Q4 | 16 Feb 2023 | After Market | ±7.5% | +5.99% | 符合区间 |
| 2022/Q3 | 27 Oct 2022 | After Market | ±12.2% | -7.98% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$651.00M-0.1% YoY
营业利润$72.60M-5.8% YoY
净利润$371.40M+16.9% YoY
摊薄每股收益$13.85+18.7% YoY
自由现金流$66.70M-5.8% YoY
经营现金流$98.70M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率51.9%
营业利润率8.7%
净利率8.6%
净资产收益率3.1%
资产收益率2.2%
投入资本回报率2.3%
流动比率3.14
负债/资产比率30.0%
现金及投资$1.62B
总负债$1.34B
净现金（净负债）$281.70M
自由现金流/营收13.6%
暂无评论——快来第一个聊聊 BIO。